167 related articles for article (PubMed ID: 11153392)
1. Pneumonia due to resistant Streptococcus pneumoniae.
Täuber MG
Schweiz Med Wochenschr; 2000 Dec; 130(49):1873-9. PubMed ID: 11153392
[TBL] [Abstract][Full Text] [Related]
2. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
5. Resistance among Streptococcus pneumoniae: Implications for drug selection.
Appelbaum PC
Clin Infect Dis; 2002 Jun; 34(12):1613-20. PubMed ID: 12032897
[TBL] [Abstract][Full Text] [Related]
6. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
[TBL] [Abstract][Full Text] [Related]
7. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
9. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pneumococcal pneumonia.
Pallares R
Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
[TBL] [Abstract][Full Text] [Related]
11. [Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia: clinical relevance of antibiotic resistance].
Bédos JP; Bruneel F
Med Mal Infect; 2006; 36(11-12):667-79. PubMed ID: 16842956
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
13. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
Brauers J; Ewig S; Kresken M
Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
[TBL] [Abstract][Full Text] [Related]
14. [No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients].
Stephan C; Just-Nübling G; Franck S; Bickel M; Shah PM; Babacan E; Staszewski S
Med Klin (Munich); 2008 Feb; 103(2):69-74. PubMed ID: 18270662
[TBL] [Abstract][Full Text] [Related]
15. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?
Peterson LR
Clin Infect Dis; 2006 Jan; 42(2):224-33. PubMed ID: 16355333
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia.
Chenoweth CE; Saint S; Martinez F; Lynch JP; Fendrick AM
Mayo Clin Proc; 2000 Nov; 75(11):1161-8. PubMed ID: 11075746
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
[TBL] [Abstract][Full Text] [Related]
18. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
19. [New quinolones for the treatment of community-acquired pneumonia--contra].
Egger M
Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
[No Abstract] [Full Text] [Related]
20. Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004).
Draghi DC; Jones ME; Sahm DF; Tillotson GS
Int J Antimicrob Agents; 2006 Dec; 28(6):525-31. PubMed ID: 17101260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
